TD Asset Management
ORKA

TD Asset Management’s Oruka Therapeutics ORKA Stock Holding History

TD Asset Management’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.8M Buy
102,944
+27,248
+36% +$1.82M 0.01% 662
2026
Q1 		$3.71M Sell
75,696
-4,200
-5% -$146K ﹤0.01% 842
2025
Q4 		$2.42M Buy
79,896
+34,020
+74% +$948K ﹤0.01% 932
2025
Q3 		$882K Hold
45,876
– – ﹤0.01% 1111
2025
Q2 		$514K Hold
45,876
– – ﹤0.01% 1131
2025
Q1 		$471K Sell
45,876
-49,200
-52% -$614K ﹤0.01% 1148
2024
Q4 		$1.84M Hold
95,076
– – ﹤0.01% 1033
2024
Q3 		$2.17M Buy
+95,076
New +$3.31M ﹤0.01% 1003

Other funds holding ORKA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
RCP
Remedium Capital Partners Fort Lauderdale, Florida $452M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

TD Asset Management's ORKA Position: Q2 2026 in Review

TD Asset Management increased its Oruka Therapeutics (ORKA) stake by 36% in Q2 2026, buying an estimated $1.82M and bringing the position to 102,944 shares worth $9.8M. The position accounts for 0.01% of the portfolio, ranked #662.

TD Asset Management first reported a position in ORKA in Q3 2024 and has held it in 8 quarters since. 159 funds tracked by Wall St. Rank hold ORKA as of Q2 2026.

  • TD Asset Management held 102,944 shares of Oruka Therapeutics worth $9.8M as of Q2 2026.
  • TD Asset Management bought 27,248 Oruka Therapeutics shares in Q2 2026, an estimated $1.82M.
  • Oruka Therapeutics made up 0.01% of TD Asset Management's portfolio in Q2 2026, its #662 holding.
  • TD Asset Management first reported a position in Oruka Therapeutics in Q3 2024 and has held it in 8 quarters since.
  • 159 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2026.

Based on TD Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.